Ixabepilone, a novel epothilone analog in the treatment of breast cancer. - Archive ouverte HAL Access content directly
Journal Articles Expert Opinion on Investigational Drugs Year : 2008

Ixabepilone, a novel epothilone analog in the treatment of breast cancer.

(1, 2) , (2) , (2) , (2) , (2) , (2) , (2) , (1, 2)
1
2

Abstract

BACKGROUND: Natural epothilones and their analogs promote tumor cell death by binding to tubulin and stabilizing microtubules, causing cell death. Ixabepilone (BMS-247550, Ixempra) is an epothilone analog that optimizes the properties naturally observed with epothilone B. OBJECTIVE: To provide an overview of the results achieved by ixabepilone in metastatic breast cancer. METHODS: A PubMed search was performed to provide an extensive review of all published data on ixabepilone, in addition to all data reported from international congresses, from 2003 to 2007. RESULTS/CONCLUSION: There is a clear need for new agents active against resistant metastatic breast cancer and ixabepilone might be a welcome new compound in this situation.
Not file

Dates and versions

inserm-00483392 , version 1 (14-05-2010)

Identifiers

Cite

Xavier B. Pivot, Christian Villanueva, Loïc Chaigneau, Thierry Nguyen, Martin Demarchi, et al.. Ixabepilone, a novel epothilone analog in the treatment of breast cancer.. Expert Opinion on Investigational Drugs, 2008, 17 (4), pp.593-9. ⟨10.1517/13543784.17.4.593⟩. ⟨inserm-00483392⟩

Collections

INSERM UNIV-FCOMTE
48 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More